http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#Head
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#provenance
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#pubinfo
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion
http://purl.obolibrary.org/obo/DOID_13884
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_13884
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB04861
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
http://www.w3.org/2000/01/rdf-schema#label
"Nebivolol Tablets are contraindicated in the following conditions: * Severe bradycardia * Heart block greater than first degree * Patients with cardiogenic shock * Decompensated cardiac failure * Sick sinus syndrome (unless a permanent pacemaker is in place) * Patients with severe hepatic impairment (Child-Pugh >B) * Patients who are hypersensitive to any component of this product * Severe bradycardia (4) * Heart block greater than first degree (4) * Patients with cardiogenic shock (4) * Decompensated cardiac failure (4) * Sick sinus syndrome (unless a permanent pacemaker is in place) (4) * Patients with severe hepatic impairment (Child-Pugh >B) (4) * Hypersensitive to any component of this product (4)"
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB04861
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#provenance
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#pubinfo
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig
http://purl.org/nanopub/x/hasSignature
FMtsyGe/0Q76OGNTIVlFrDFqPsDSIPLli+mQmwALJL5IlP45AFVJt0JPK3Rc6FuiEtEiRs0efqglxAzDnoeEwjKX7xv67eIklwpNK4ymEcUGFoXj28jB1HoSAI/V7U/Yl9z8I8i1cS81jVZaawfE8wShiQg9e3oOpg+TZJk9QKQ=
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://purl.org/dc/terms/created
2021-08-23T12:39:25.045+02:00
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY